Patent · US Active

Compositions and methods for achieving sustained therapeutic drug concentrations in a subject

US10525051B2 · kind B2 · utility

3Cited by
19References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 3, 2017
Grant dateJan 7, 2020
Priority date—
Expiry dateOct 3, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are compounds and methods for achieving a sustained therapeutic effect of small molecule anti-cancer agents when administered in vivo.Sustained Exposure to Active Metabolite with PEG-Irinotecan

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.